Log in to save to my catalogue

Impact of measurable residual disease by decentralized flow cytometry: a PETHEMA real-world study in...

Impact of measurable residual disease by decentralized flow cytometry: a PETHEMA real-world study in...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2485520777

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

The role of decentralized assessment of measurable residual disease (MRD) for risk stratification in acute myeloid leukemia (AML) remains largely unknown, and so it does which methodological aspects are critical to empower the evaluation of MRD with prognostic significance, particularly if using multiparameter flow cytometry (MFC). We analyzed 1076...

Alternative Titles

Full title

Impact of measurable residual disease by decentralized flow cytometry: a PETHEMA real-world study in 1076 patients with acute myeloid leukemia

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2485520777

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2485520777

Other Identifiers

ISSN

0887-6924

E-ISSN

1476-5551

DOI

10.1038/s41375-021-01126-3

How to access this item